Tapewire

Nasdaq · USD

CPIX

CUMBERLAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
6757
SEC CIK
0001087294
Parsed reports
362

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 30, 2018 Filed Aug 31, 2018 21:14 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
GiftCommon Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-049111 · doc4.xml · nonDerivative · entry 1

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,705,897

F1 · shares: Represents a share transfer to a family trust with other beneficial owners.

Read SEC document
August 29, 2018 Filed Aug 31, 2018 21:19 UTC
Bonner MichaelChief Financial Officer
PurchaseCommon Stock 100 $6.24 $624.00
Disclosure

SEC source: 0001209191-18-049112 · doc4.xml · nonDerivative · entry 2

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,454

Read SEC document
August 28, 2018 Filed Aug 31, 2018 21:19 UTC
Bonner MichaelChief Financial Officer
PurchaseCommon Stock 300 $5.92 $1,776.00
Disclosure

SEC source: 0001209191-18-049112 · doc4.xml · nonDerivative · entry 1

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,354

Read SEC document
May 17, 2018 Filed May 18, 2018 21:11 UTC
Bonner MichaelChief Financial Officer
PurchaseCommon Stock 400 $6.12 $2,448.00
Disclosure

SEC source: 0001209191-18-031475 · doc4.xml · nonDerivative · entry 1

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,054

Read SEC document
April 04, 2018 Filed Apr 12, 2019 21:17 UTC PurchaseCommon Stock 241 $6.19 $1,491.79
Disclosure

SEC source: 0001209191-19-024503 · doc4.xml · nonDerivative · entry 4

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,633

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:46 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
Tax withholdingCommon Stock 890 $6.70 $5,963.00
Disclosure

SEC source: 0001209191-18-021485 · doc4.xml · nonDerivative · entry 2

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,667

F2 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:46 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
GrantCommon Stock 5,000 $6.70 $33,500.00
Disclosure

SEC source: 0001209191-18-021485 · doc4.xml · nonDerivative · entry 1

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,557

F1 · shares: Restricted stock award will vest 100% on March 20, 2022.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:45 UTC
Pavliv LeoSVP and Chief Development Off.
Tax withholdingCommon Stock 2,557 $6.70 $17,131.90
Disclosure

SEC source: 0001209191-18-021483 · doc4.xml · nonDerivative · entry 2

Pavliv Leo · CIK 0001408593 · SVP and Chief Development Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,304

F2 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:45 UTC
Pavliv LeoSVP and Chief Development Off.
GrantCommon Stock 25,000 $6.70 $167,500.00
Disclosure

SEC source: 0001209191-18-021483 · doc4.xml · nonDerivative · entry 1

Pavliv Leo · CIK 0001408593 · SVP and Chief Development Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,861

F1 · shares: Restricted stock award will vest 100% on March 20, 2022.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:45 UTC
Herman James LVP and Chief Compliance Office
Tax withholdingCommon Stock 2,999 $6.70 $20,093.30
Disclosure

SEC source: 0001209191-18-021481 · doc4.xml · nonDerivative · entry 2

Herman James L · CIK 0001572342 · VP and Chief Compliance Office

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,949

F2 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:45 UTC
Herman James LVP and Chief Compliance Office
GrantCommon Stock 3,000 $6.70 $20,100.00
Disclosure

SEC source: 0001209191-18-021481 · doc4.xml · nonDerivative · entry 1

Herman James L · CIK 0001572342 · VP and Chief Compliance Office

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,948

F1 · shares: Restricted stock award will vest 100% on March 20, 2022.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:44 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
Tax withholdingCommon Stock 24,373 $6.70 $163,299.10
Disclosure

SEC source: 0001209191-18-021478 · doc4.xml · nonDerivative · entry 2

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,905,897

F2 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:44 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
GrantCommon Stock 100,000 $6.70 $670,000.00
Disclosure

SEC source: 0001209191-18-021478 · doc4.xml · nonDerivative · entry 1

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,930,270

F1 · shares: Restricted stock award will vest 100% on March 20, 2022.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:44 UTC GrantCommon Stock 1,000 $6.70 $6,700.00
Disclosure

SEC source: 0001209191-18-021475 · doc4.xml · nonDerivative · entry 1

Bernard Gordon R · CIK 0001470015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,729

F1 · shares: Restricted stock award will vest 100% on March 20, 2019.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:43 UTC GrantCommon Stock 1,000 $6.70 $6,700.00
Disclosure

SEC source: 0001209191-18-021474 · doc4.xml · nonDerivative · entry 1

Griggs Jonathan · CIK 0001490828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,803

F1 · shares: Restricted stock award will vest 100% on March 20, 2019.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:43 UTC
Jones JamesDirector
GrantCommon Stock 1,000 $6.70 $6,700.00
Disclosure

SEC source: 0001209191-18-021472 · doc4.xml · nonDerivative · entry 1

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,700

F1 · shares: Restricted stock award will vest 100% on March 20, 2019.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:42 UTC GrantCommon Stock 1,000 $6.70 $6,700.00
Disclosure

SEC source: 0001209191-18-021470 · doc4.xml · nonDerivative · entry 1

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

F1 · shares: Restricted stock award will vest 100% on March 20, 2019.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:42 UTC GrantCommon Stock 1,000 $6.70 $6,700.00
Disclosure

SEC source: 0001209191-18-021468 · doc4.xml · nonDerivative · entry 1

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,300

F1 · shares: Restricted stock award will vest 100% on March 20, 2019.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:41 UTC GrantCommon Stock 5,000 $6.70 $33,500.00
Disclosure

SEC source: 0001209191-18-021465 · doc4.xml · nonDerivative · entry 1

JACOBS JOEY A · CIK 0001243878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,000

F1 · shares: Restricted stock award will vest 100% on March 20, 2019.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:40 UTC
Bonner MichaelChief Financial Officer
Tax withholdingCommon Stock 843 $6.70 $5,648.10
Disclosure

SEC source: 0001209191-18-021463 · doc4.xml · nonDerivative · entry 3

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,654

F2 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
March 23, 2018 Filed Mar 23, 2018 21:40 UTC
Bonner MichaelChief Financial Officer
GrantCommon Stock 2,500 $6.70 $16,750.00
Disclosure

SEC source: 0001209191-18-021463 · doc4.xml · nonDerivative · entry 2

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,497

F1 · shares: Restricted stock award will vest 100% on March 20, 2022.

Read SEC document
March 19, 2018 Filed Mar 23, 2018 21:40 UTC
Bonner MichaelChief Financial Officer
PurchaseCommon Stock 300 $6.72 $2,016.00
Disclosure

SEC source: 0001209191-18-021463 · doc4.xml · nonDerivative · entry 1

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,997

Read SEC document
November 22, 2017 Filed Nov 24, 2017 22:15 UTC
Bonner MichaelChief Financial Officer
PurchaseCommon Stock 250 $7.81 $1,952.50
Disclosure

SEC source: 0001209191-17-062464 · doc4.xml · nonDerivative · entry 1

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,697

Read SEC document
November 20, 2017 Filed Nov 24, 2017 22:17 UTC PurchaseCommon Stock 3,300 $7.55 $24,915.00
Disclosure

SEC source: 0001209191-17-062466 · doc4.xml · nonDerivative · entry 1

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,300

Read SEC document
August 23, 2017 Filed Aug 25, 2017 20:57 UTC
Bonner MichaelChief Financial Officer
PurchaseCommon Stock 500 $6.72 $3,360.00
Disclosure

SEC source: 0001209191-17-050310 · doc4.xml · nonDerivative · entry 1

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,447

Read SEC document
May 31, 2017 Filed Jun 2, 2017 21:23 UTC GrantCommon Stock 4,000 $6.53 $26,120.00
Disclosure

SEC source: 0001209191-17-037368 · doc4.xml · nonDerivative · entry 1

JACOBS JOEY A · CIK 0001243878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,000

F1 · shares: Restricted stock award will vest 100% on May 19, 2018.

Read SEC document
May 31, 2017 Filed Jun 2, 2017 21:21 UTC
Bonner MichaelChief Financial Officer
PurchaseCommon Stock 300 $6.95 $2,085.00
Disclosure

SEC source: 0001209191-17-037364 · doc4.xml · nonDerivative · entry 1

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,947

Read SEC document
May 31, 2017 Filed Jun 2, 2017 21:22 UTC SaleCommon Stock 8,000 $6.97 $55,760.00
Disclosure

SEC source: 0001209191-17-037366 · doc4.xml · nonDerivative · entry 1

Griggs Jonathan · CIK 0001490828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,803

F1 · shares: Shares sold to Cumberland Pharmaceuticals Inc.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 21:03 UTC GrantCommon Stock 1,000 $6.45 $6,450.00
Disclosure

SEC source: 0001209191-17-026320 · doc4.xml · nonDerivative · entry 1

Griggs Jonathan · CIK 0001490828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,803

F1 · shares: Restricted stock award will vest 100% on March 17, 2018.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 20:55 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
Tax withholdingCommon Stock 13,575 $6.45 $87,558.75
Disclosure

SEC source: 0001209191-17-026304 · doc4.xml · nonDerivative · entry 2

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,845,270

F2 · shares: This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 50,000 shares during March 2017.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 20:55 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
GrantCommon Stock 100,000 $6.45 $645,000.00
Disclosure

SEC source: 0001209191-17-026304 · doc4.xml · nonDerivative · entry 1

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,858,845

F1 · shares: Restricted stock award will vest 100% on March 17, 2021.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 21:07 UTC GrantCommon Stock 2,000 $6.45 $12,900.00
Disclosure

SEC source: 0001209191-17-026329 · doc4.xml · nonDerivative · entry 1

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

F1 · shares: Restricted stock award will vest 100% on March 17, 2018.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 21:06 UTC GrantCommon Stock 1,000 $6.45 $6,450.00
Disclosure

SEC source: 0001209191-17-026326 · doc4.xml · nonDerivative · entry 1

JACOBS JOEY A · CIK 0001243878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,000

F1 · shares: Restricted stock award will vest 100% on March 17, 2018.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 21:05 UTC GrantCommon Stock 1,000 $6.45 $6,450.00
Disclosure

SEC source: 0001209191-17-026324 · doc4.xml · nonDerivative · entry 1

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,000

F1 · shares: Restricted stock award will vest 100% on March 17, 2018.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 21:04 UTC
Jones JamesDirector
GrantCommon Stock 1,000 $6.45 $6,450.00
Disclosure

SEC source: 0001209191-17-026322 · doc4.xml · nonDerivative · entry 1

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,700

F1 · shares: Restricted stock award will vest 100% on March 17, 2018.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 21:02 UTC GrantCommon Stock 1,000 $6.45 $6,450.00
Disclosure

SEC source: 0001209191-17-026317 · doc4.xml · nonDerivative · entry 1

Bernard Gordon R · CIK 0001470015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,729

F1 · shares: Restricted stock award will vest 100% on March 17, 2018.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 21:00 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
Tax withholdingCommon Stock 1,959 $6.45 $12,635.55
Disclosure

SEC source: 0001209191-17-026310 · doc4.xml · nonDerivative · entry 2

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,557

F2 · shares: This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 6,000 shares during March 2017.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 21:00 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
GrantCommon Stock 11,600 $6.45 $74,820.00
Disclosure

SEC source: 0001209191-17-026310 · doc4.xml · nonDerivative · entry 1

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,516

F1 · shares: Restricted stock award will vest 100% on March 17, 2021.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 21:01 UTC SaleCommon Stock 6,000 $6.40 $38,400.00
Disclosure

SEC source: 0001209191-17-026315 · doc4.xml · nonDerivative · entry 1

Lawrence Thomas R · CIK 0001408568 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Shares transferred to accredited investor

Read SEC document
April 07, 2017 Filed Apr 7, 2017 20:58 UTC
Herman James LVP and Chief Compliance Office
Tax withholdingCommon Stock 1,796 $6.45 $11,584.20
Disclosure

SEC source: 0001209191-17-026307 · doc4.xml · nonDerivative · entry 2

Herman James L · CIK 0001572342 · VP and Chief Compliance Office

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,948

F2 · shares: This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 5,500 shares during March 2017.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 20:58 UTC
Herman James LVP and Chief Compliance Office
GrantCommon Stock 6,000 $6.45 $38,700.00
Disclosure

SEC source: 0001209191-17-026307 · doc4.xml · nonDerivative · entry 1

Herman James L · CIK 0001572342 · VP and Chief Compliance Office

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,744

F1 · shares: Restricted stock award will vest 100% on March 17, 2021.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 20:53 UTC
Pavliv LeoSVP and Chief Development Off.
Tax withholdingCommon Stock 3,582 $6.45 $23,103.90
Disclosure

SEC source: 0001209191-17-026299 · doc4.xml · nonDerivative · entry 2

Pavliv Leo · CIK 0001408593 · SVP and Chief Development Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,861

F2 · shares: This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 10,000 shares during March 2017.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 20:53 UTC
Pavliv LeoSVP and Chief Development Off.
GrantCommon Stock 10,000 $6.45 $64,500.00
Disclosure

SEC source: 0001209191-17-026299 · doc4.xml · nonDerivative · entry 1

Pavliv Leo · CIK 0001408593 · SVP and Chief Development Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,443

F1 · shares: Restricted stock award will vest 100% on March 17, 2021.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 20:52 UTC
Bonner MichaelChief Financial Officer
Tax withholdingCommon Stock 653 $6.45 $4,211.85
Disclosure

SEC source: 0001209191-17-026295 · doc4.xml · nonDerivative · entry 2

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,647

F2 · shares: This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 2,000 shares during March 2017.

Read SEC document
April 07, 2017 Filed Apr 7, 2017 20:52 UTC
Bonner MichaelChief Financial Officer
GrantCommon Stock 2,500 $6.45 $16,125.00
Disclosure

SEC source: 0001209191-17-026295 · doc4.xml · nonDerivative · entry 1

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,300

F1 · shares: Restricted stock award will vest 100% on March 17, 2021.

Read SEC document
March 23, 2017 Filed Mar 24, 2017 21:00 UTC
Bonner MichaelChief Financial Officer
PurchaseCommon Stock 900 $6.42 $5,778.00
Disclosure

SEC source: 0001209191-17-022787 · doc4.xml · nonDerivative · entry 1

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,800

Read SEC document
March 21, 2017 Filed Mar 24, 2017 20:59 UTC PurchaseCommon Stock 15,000 $6.53 $97,950.00
Disclosure

SEC source: 0001209191-17-022785 · doc4.xml · nonDerivative · entry 1

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Read SEC document
March 13, 2017 Filed Mar 15, 2017 21:00 UTC SaleCommon Stock 20,781 $6.24 $129,673.44
Disclosure

SEC source: 0001209191-17-020844 · doc4.xml · nonDerivative · entry 1

Lawrence Thomas R · CIK 0001408568 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

F1 · shares: Shares transferred to accredited investor

Read SEC document
November 17, 2016 Filed Nov 18, 2016 22:13 UTC
Bonner MichaelChief Financial Officer
PurchaseCommon Stock 900 $5.50 $4,950.00
Disclosure

SEC source: 0001209191-16-151281 · doc4.xml · nonDerivative · entry 1

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,900

Read SEC document
November 15, 2016 Filed Nov 18, 2016 22:14 UTC SaleCommon Stock 18,600 $5.07 $94,302.00
Disclosure

SEC source: 0001209191-16-151282 · doc4.xml · nonDerivative · entry 1

Lawrence Thomas R · CIK 0001408568 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,781

F1 · shares: Shares sold to Cumberland Pharmaceuticals Inc.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.